Miclot to head ArthroCare’s ENT unit
This article was originally published in Clinica
ArthroCare has appointed Andrew Miclotas senior vice-president, general manager of its ear, nose and throat (ENT) business. Mr Miclot has over 25 years’ experience in the medical device industry, primarily in the orthopaedics sector. He was most recently president and CEO of Ascension Orthopedics. In his new role at ArthroCare, Mr Miclot will manage the Austin, Texas firm’s worldwide ENT product lines, used by surgeons in tonsil- and adenoid-removal procedures and the treatment of snoring. ArthroCare’s products are based on its proprietary low-temperature, radiofrequency Coblation technology.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.